The United Bio-Technology (Hengqin) Co., Ltd. clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19
What changed in the last 30 days
3 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 2 with minor changes only.
- Minor: Food Effect of UBT48128 Tablets in Healthy Participants Study completion pushed from Dec 30, 2026 to Mar 31, 2027
- Notable: UBT37034 Injection Recruitment opened
- Minor: UBT251 Injection Phase Ⅲ Study (Overweight or Obesity) Trial status changed: Not Yet Recruiting → Active, Not Recruiting
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New trial filings, last 30 days
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-11-06 | NCT07922798 A Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effect… | Phase 1 | Not Yet Recruiting |
Active trials by phase
| Phase 1 | 4 | |
| Phase 2 | 2 | |
| Phase 3 | 5 |
Disease areas by active trials
Obesity (7) · Diabetes (3) · Type 2 Diabetes (3) · Chronic Kidney Disease (1) · NASH / MASH (1)
Get alerts when The United Bio-Technology (Hengqin) Co., Ltd.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.